These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31631860)

  • 1. 15-Year Trends in Patients Hospitalised With Heart Failure and Enrolled in an Australian Heart Failure Management Program.
    Wang N; Hales S; Tofler G
    Heart Lung Circ; 2019 Nov; 28(11):1646-1654. PubMed ID: 31631860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality.
    Platz E; Jhund PS; Claggett BL; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Solomon SD; McMurray JJ
    Eur J Heart Fail; 2018 Feb; 20(2):295-303. PubMed ID: 28872259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction.
    Chamberlain AM; Gersh BJ; Alonso A; Kopecky SL; Killian JM; Weston SA; Roger VL
    Heart Rhythm; 2017 Jun; 14(6):791-798. PubMed ID: 28119130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes following heart failure hospitalization in a regional Australian setting between 2005 and 2014.
    Al-Omary MS; Khan AA; Davies AJ; Fletcher PJ; Mcivor D; Bastian B; Oldmeadow C; Sverdlov AL; Attia JR; Boyle AJ
    ESC Heart Fail; 2018 Apr; 5(2):271-278. PubMed ID: 29265710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results From the China Heart Failure (China-HF) Registry.
    Zhang Y; Zhang J; Butler J; Yang X; Xie P; Guo D; Wei T; Yu J; Wu Z; Gao Y; Han X; Zhang X; Wen S; Anker SD; Filippatos G; Fonarow GC; Gan T; Zhang R;
    J Card Fail; 2017 Dec; 23(12):868-875. PubMed ID: 29029965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with heart failure: an observational report from the Middle East.
    Khafaji HA; Sulaiman K; Singh R; AlHabib KF; Asaad N; Alsheikh-Ali A; Al-Jarallah M; Bulbanat B; AlMahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; AlFaleh H; Elasfar A; Panduranga P; Al Suwaidi J
    BMJ Open; 2015 Apr; 5(4):e007148. PubMed ID: 25908674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and seasonal variation of precipitants of heart failure hospitalization and risk of readmission.
    Wang N; Farrell M; Hales S; Hanvey K; Robertson G; Sharp P; Tofler G
    Int J Cardiol; 2020 Oct; 316():152-160. PubMed ID: 32360644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.
    Steinberg BA; Zhao X; Heidenreich PA; Peterson ED; Bhatt DL; Cannon CP; Hernandez AF; Fonarow GC;
    Circulation; 2012 Jul; 126(1):65-75. PubMed ID: 22615345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized management of heart failure patients aged 80 years or more improves outcomes versus usual care: The HF80 randomized trial.
    Vorilhon C; Jean F; Mulliez A; Clerfond G; Pereira B; Sapin V; Souteyrand G; Citron B; Motreff P; Lusson JR; Eschalier R
    Arch Cardiovasc Dis; 2016 Dec; 109(12):667-678. PubMed ID: 27825591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
    Hoong CW; Lim CP; Gao F; Chen Q; Kawa LB; Ching CK; Sim DK
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):583-90. PubMed ID: 25022929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure.
    Llorens P; Javaloyes P; Martín-Sánchez FJ; Jacob J; Herrero-Puente P; Gil V; Garrido JM; Salvo E; Fuentes M; Alonso H; Richard F; Lucas FJ; Bueno H; Parissis J; Müller CE; Miró Ò;
    Clin Res Cardiol; 2018 Oct; 107(10):897-913. PubMed ID: 29728831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
    J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Transitional Care on 30-Day Outcomes in Patients Hospitalised With Acute Heart Failure.
    Driscoll A; Dinh D; Prior D; Kaye D; Hare D; Neil C; Lockwood S; Brennan A; Lefkovits J; Carruthers H; Amerena J; Cooke JC; Vaddadi G; Nadurata V; Reid CM
    Heart Lung Circ; 2020 Sep; 29(9):1347-1355. PubMed ID: 32359870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
    Masson S; Batkai S; Beermann J; Bär C; Pfanne A; Thum S; Magnoli M; Balconi G; Nicolosi GL; Tavazzi L; Latini R; Thum T
    Eur J Heart Fail; 2018 Jan; 20(1):78-85. PubMed ID: 29027324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcome for heart failure patients with mid-range ejection fraction.
    Wang N; Hales S; Barin E; Tofler G
    J Cardiovasc Med (Hagerstown); 2018 Jun; 19(6):297-303. PubMed ID: 29570491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction.
    Lund LH; Donal E; Oger E; Hage C; Persson H; Haugen-Löfman I; Ennezat PV; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
    Eur J Heart Fail; 2014 Sep; 16(9):992-1001. PubMed ID: 25046483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
    Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.